Susquehanna International Group, LLP Neogenomics Inc Transaction History
Susquehanna International Group, LLP
- $560 Billion
- Q3 2024
A detailed history of Susquehanna International Group, LLP transactions in Neogenomics Inc stock. As of the latest transaction made, Susquehanna International Group, LLP holds 28,747 shares of NEO stock, worth $432,354. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,747
Previous 37,567
23.48%
Holding current value
$432,354
Previous $521,000
18.62%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding NEO
# of Institutions
295Shares Held
125MCall Options Held
698KPut Options Held
120K-
Black Rock Inc. New York, NY19.7MShares$296 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14MShares$211 Million0.0% of portfolio
-
Brown Advisory Inc6.89MShares$104 Million0.13% of portfolio
-
Janus Henderson Group PLC London, X06.6MShares$99.3 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.54MShares$98.4 Million0.06% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.89B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...